Table 1a.
Estimated population attributable fraction (PAF, %) and cancer cases (N) and their 90% uncertainty intervals associated with excess body mass index by world region and cancer site in 2012, males.
| Region | Oesophageal adenocarcinoma |
Colon | Rectum | Pancreas | Kidney | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PAF | N | PAF | N | PAF | N | PAF | N | PAF | N | N | PAF obesitya | PAF allb | |
| Sub-Saharan Africa | 15% (11 %-21 %) | 125 (88-169) | 5% (4%-7%) | 330 (235-457) | 3% (2%-4%) | 144 (103-199) | 4% (3%-6%) | 175 (132-227) | 6% (4%-8%) | 94 (68-129) | 867 (625-1181) | 5% (3%-6%) | 0-4% (0-3%-0-5%) |
| Middle East and Northern Africa | 34% (28%-41%) | 391 (323-462) | 16% (14%-18%) | 2111 (1831-2395) | 8% (7%-9%) | 631 (547-719) | 11% (9%-12%) | 697 (608-788) | 20% (17%-22%) | 1150 (1018-1282) | 4980 (4327-5646) | 14% (13%-16%) | 2-0% (1-7%-2-2%) |
| Latin America & Caribbean | 36% (32%-39%) | 1193 (1063-1312) | 15% (13%-17%) | 4058 (3520-4590) | 8% (7%-9%) | 1099 (953-1248) | 10% (9%-11%) | 1294 (1123-1470) | 19% (17%-21%) | 2366 (2080-2639) | 10009 (8739-11258) | 14% (13%-16%) | 2-0% (1-7%-2-2%) |
| North America | 44% (46%-50%) | 4293 (4456-4804) | 21% (20%-22%) | 11453 (10861-12002) | 11% (10%-12%) | 2792 (2638-2941) | 14% (13%-15%) | 3390 (3208-3578) | 25% (24%-26%) | 9801 (9307-10270) | 31729 (30470-33595) | 21% (20%-22%) | 3-5% (3-4%-3-7%) |
| East Asia | 18% (15%-20%) | 1390 (1200-1587) | 7% (6%-8%) | 9120 (7797-10534) | 3% (3%-4%) | 3386 (2888-3926) | 4% (4%-5%) | 2625 (2246-3041) | 8% (7%-9%) | 4878 (4201-5632) | 21398 (18332-24720) | 6% (5%-7%) | 0-9% (0-8%-1-1%) |
| South-East Asia | 14% (10%-19%) | 91 (66-128) | 4% (3%-6%) | 951 (659-1325) | 2% (1%-3%) | 301 (208-421) | 3% (2%-4%) | 165 (111-234) | 6% (4%-8%) | 248 (177-337) | 1756 (1221-2444) | 4% (2%-5%) | 0-5% (0-3%-0-7%) |
| South-Central Asia | 10% (7%-13%) | 389 (266-527) | 4% (3%-5%) | 997 (736-1277) | 2% (1%-2%) | 353 (246-476) | 3% (2%-4%) | 255 (185-332) | 5% (4%-7%) | 481 (350-623) | 2474 (1783-3235) | 4% (3%-5%) | 0-4% (0-3%-0-5%) |
| Eastern Europe | 38% (33%-43%) | 637 (549-716) | 16% (14%-19%) | 6082 (5141-7021) | 8% (7%-10%) | 2586 (2144-3049) | 10% (9%-12%) | 1829 (1538-2130) | 19% (16%-21%) | 4382 (3744-5016) | 15517 (13115-17931) | 14% (12%-16%) | 3-1% (2-6%-3-6%) |
| Northern Europe | 44% (42%-46%) | 2262 (2139-2369) | 18% (17%-20%) | 3756 (3447-4046) | 9% (9%-10%) | 1337 (1221-1452) | 12% (11%-13%) | 845 (769-919) | 22% (20%-23%) | 2042 (1867-2202) | 10242 (9443-10989) | 18% (17%-20%) | 3-8% (3-5%-4-1%) |
| Southern Europe | 43% (40%-46%) | 527 (484-564) | 18% (16%-20%) | 7002 (6295-7667) | 9% (8%-10%) | 1930 (1717-2142) | 12% (11%-13%) | 1379 (1223-1533) | 21% (19%-23%) | 3206 (2873-3514) | 14044 (12593-15421) | 16% (14%-18%) | 3-3% (3-0%-3-6%) |
| Western Europe | 43% (38%-46%) | 1911 (1705-2083) | 19% (17%-21%) | 8536 (7586-9447) | 10% (9%-11%) | 2847 (2529-3167) | 12% (11%-14%) | 1959 (1742-2178) | 22% (20%-24%) | 4984 (4461-5488) | 20236 (18023-22364) | 17% (15%-19%) | 3-3% (3-0%-3-7%) |
| Oceania | 44% (42%-46%) | 361 (340-379) | 19% (18%-20%) | 1212 (1131-1292) | 10% (9%-11%) | 399 (371-427) | 13% (12%-14%) | 233 (216-250) | 23% (21%-24%) | 600 (560-637) | 2804 (2619-2985) | 18% (17%-19%) | 3-4% (3-2%-3-6%) |
| Low HDIc | 8% (3%-15%) | 175 (64-326) | 3% (2%-6%) | 341 (165-634) | 2% (1%-3%) | 127 (61-239) | 2% (1%-4%) | 117 (63-199) | 4% (2%-7%) | 134 (62-243) | 895 (414-1642) | 3% (1%-6%) | 0-3% (0-1%-0-5%) |
| Medium HDI | 16% (14%-19%) | 1703 (1425-1991) | 6% (5%-7%) | 7399 (6037-8894) | 3% (2%-3%) | 2778 (2268-3346) | 4% (3%-5%) | 2340 (1939-2788) | 8% (6%-9%) | 4365 (3675-5135) | 18584 (15343-22154) | 5% (4%-6%) | 0-7% (0-6%-0-8%) |
| High HDI | 34% (30%-38%) | 1735 (1527-1926) | 14% (12%-17%) | 8533 (7289-9775) | 7% (6%-9%) | 3104 (2610-3620) | 10% (8%-11%) | 2717 (2312-3132) | 17% (15%-20%) | 5437 (4695-6178) | 21527 (18433-24630) | 13% (11%-15%) | 2-1% (1-8%-2-4%) |
| Very high HDI | 43% (42%-47%) | 9955 (9664-10857) | 17% (15%-18%) | 39335 (35748-42749) | 8% (8%-9%) | 11795 (10626-12963) | 11% (10%-12%) | 9672 (8787-10560) | 21% (19%-23%) | 24295 (22275-26213) | 95052 (87100-103344) | 16% (15%-17%) | 3-2% (2-9%-3-4%) |
| World | 33% (31%-37%) | 13569 (12680-15100) | 13% (11%-14%) | 55608 (49239-62052) | 6% (5%-7%) | 17804 (15565-20168) | 8% (7%-9%) | 14845 (13100-16680) | 17% (15%-18%) | 34231 (30707-37769) | 136058 (121291-151769) | 12% (11%-13%) | 1-9% (1-7%-2-1%) |
a
PAF obesity: proportion of obesity-related cancers (i.e. oesophageal adenocarcinoma, pancreas, kidney, colon, rectum)attributable to excess BMI
b
PAF all cancers: proportion of all cancer (excluding non-melanoma skin cancers) attributable to excess BMI
c
HDI: Human development index